Nordmark Competitors and Similar CompaniesClear all

Nordmark's competitors and similar companies include EMS Pharma, Genentech, UCB and Cipla.

	Nordmark Nordmark is a company engaged in the development and production of biological active pharmaceutical ingredients and drug products.	EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
Founding Date	Founding Date 2001	Founding Date 1964	Founding Date 1976	Founding Date 1928	Founding Date 1935
Type	Type Private	Type Private	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Uetersen, DE HQ Kiel, DE Pinneberg, DE	Locations BR HQ	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more
Employees	Employees 216	Employees 12,7441% increase	Employees 18,077	Employees 9,052	Employees 27,764
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) ₹277.1b (FY, 2026)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods €1.4b (FY, 2025)	Cost of goods ₹97.2b (FY, 2026)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit €7.2b (FY, 2025)	Gross profit ₹184.4b (FY, 2026)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income €1.6b (FY, 2025)	Net income ₹38.7b (FY, 2026)